Juniper Pharmaceuticals, Inc. (JNP) Starts Presentation at 2015 Marcum MicroCap Conference

Juniper Pharmaceuticals (formerly Columbia Laboratories) is a specialty pharmaceutical company focused on developing therapeutics that address unmet medical needs in women’s health.  Juniper has a successful heritage in developing pharmaceutical products, including CRINONE^® 8% (progesterone gel), which is marketed by Actavis, Inc. in the U.S. and by Merck Serono S.A. in over 60 countries worldwide. The company leverages in-house pharmaceutical development, clinical trial manufacturing and analytical capabilities to advance an internal development pipeline, while also providing valuable consultative services to its pharmaceutical industry customers. For more information, visit the company’s website at: www.juniperpharma.com